BioPharmNet
Topics
BioPharmNet forum
 
Navigation
Design and analysis of thorough QT studies
Download a copy of the white paper written by Dr. Alex Dmitrienko, Dr. Charles Beasley and Dr. Malcolm Mitchell to facilitate an open discussion of issues related to the design and analysis of thorough QT studies.
Summary
The white paper discusses design and analysis considerations in thorough QT studies. Section 2 briefly summarizes main difficulties with the measurement and analysis of QT interval and provides a high-level description of key features and outcomes of thorough QT studies. Section 3 reviews design elements that impact the probability of a negative thorough QT study. Section 4 gives an overview of common approaches to the analysis of QT interval data collected in these studies that also influence the probability of a negative outcome.
Feedback
Readers are encouraged to share their comments, thoughts and suggestions. Instructions for submitting feedback can be found on the title page of the white paper.
Discussion
Comments submitted by Dr. Scott Patterson (Wyeth).
Comments submitted by Dr. Arne Ring (Boehringer Ingelheim).
Comments submitted by Dr. Stan Young (National Institute of Statistical Sciences).